PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsSarcoma
MeSH D012509 - sarcoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018204:Connective and soft tissue neoplasms
0 Companies
0 Drugs
Success rate
D012509: 
Sarcoma
23 Companies
8 Drugs
$
Success rate
D002296:Carcinosarcoma
0 Companies
0 Drugs
Success rate
D002813:Chondrosarcoma
0 Companies
0 Drugs
Success rate
D003557:Phyllodes tumor
0 Companies
0 Drugs
Success rate
D005354:Fibrosarcoma
6 Companies
1 Drug
$
Success rate
D006394:Hemangiosarcoma
0 Companies
0 Drugs
Success rate
D007890:Leiomyosarcoma
2 Companies
1 Drug
$
Success rate
D008080:Liposarcoma
10 Companies
2 Drugs
$
Success rate
D008204:Lymphangiosarcoma
0 Companies
0 Drugs
Success rate
D009217:Myosarcoma
0 Companies
0 Drugs
Success rate
D009236:Myxosarcoma
0 Companies
0 Drugs
Success rate
D012513:Experimental sarcoma
0 Companies
0 Drugs
Success rate
D012514:Kaposi sarcoma
40 Companies
12 Drugs
$
Success rate
D012516:Osteosarcoma
46 Companies
6 Drugs
$
Success rate
D013584:Synovial sarcoma
0 Companies
0 Drugs
Success rate
D018195:Adenosarcoma
0 Companies
0 Drugs
Success rate
D018199:Mesodermal mixed tumor
0 Companies
0 Drugs
Success rate
D018227:Clear cell sarcoma
0 Companies
0 Drugs
Success rate
D018228:Small cell sarcoma
0 Companies
0 Drugs
Success rate
D018234:Alveolar soft part sarcoma
2 Companies
2 Drugs
$
Success rate
D023981:Myeloid sarcoma
0 Companies
0 Drugs
Success rate
D036821:Endometrial stromal tumors
0 Companies
0 Drugs
Success rate
D051677:Malignant fibrous histiocytoma
0 Companies
0 Drugs
Success rate
D058405:Desmoplastic small round cell tumor
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBleomycin Bleomycin  1996-06-01   
Ifosfamide, Mesna Ifosfamide/mesna  2002-02-26   
Thiotepa Thiotepa  2001-04-20   
Rising PharmaceuticalsIfosfamide Ifosfamide  2012-11-26   
Mitoxantrone Mitoxantrone  2012-12-11   
CiplaBleomycin Bleomycin  2019-03-11   
Eli LillyOlaratumab Lartruvo  2016-10-19   
Dr Reddys LaboratoriesThiotepa Thiotepa  2018-05-04   
HospiraBleomycin Bleomycin  2000-03-10   
Mitoxantrone Mitoxantrone  2006-04-11   
Bristol Myers SquibbBleomycin Blenoxane  1982-01-01   
MSN LaboratoriesThiotepa Thiotepa  2020-03-04   
Hikma PharmaceuticalsBleomycin Bleomycin  2001-10-17   
Ifosfamide Ifosfamide  2011-06-29   
Mitoxantrone Mitoxantrone  2006-04-11   
Thiotepa Thiotepa  2023-09-05   
West-Ward PharmaceuticalThiotepa Thiotepa  2001-04-02   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
73%
129/177
Phase 2
25%
53/211
Phase 3
15%
11/71
Approved: 6Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Bleomycin
Cipla
Bleomycin,
Lornoxicam,
Doxorubin,
Histone-arginine methyltransferase carm1,
Hydroxydaunomycin,
Surlorian
Eli Lilly
Olaratumab,
Docusate,
Aglatimagene besadenovec,
Vicriviroc,
Tranilast,
Lornoxicam,
TALADEGIB,
Aspartame,
Bevifimod,
CIXUTUMUMAB,
CRENIGACESTAT,
Doxecitine,
Palifosfamide,
SAMOTOLISIB,
Tasisulam,
D-glutamate,
Globulin, immune,
Anthracycline,
Endocrine,
Aminoglycoside,
Doxorubin,
Iphosphamid,
Mk3475,
Ec-17,
Curcumin,
Hydroxydaunomycin,
Docetaxol,
Taxane,
Isoxaflutole
Bristol Myers Squibb
Bleomycin,
Gilvetmab,
Spartalizumab,
Inosine,
Brivanib alaninate,
Bevifimod,
Doxecitine,
Globulin, immune,
Anthracycline,
Aminoglycoside,
Doxorubin,
Mk3475,
Antineoplaston a10,
Hydroxydaunomycin
Fresenius Kabi
Thiotepa
Baxter
Ifosfamide,
Lenograstim,
Lornoxicam,
Molgramostim,
Bevifimod,
Krestin,
Histone-arginine methyltransferase carm1
Jiangsu Hengrui Medicine
Camrelizumab,
Gilvetmab,
Rivoceranib,
Lornoxicam,
Palifosfamide,
Globulin, immune,
Anthracycline,
Aminoglycoside,
Doxorubin,
Iphosphamid,
Hydroxydaunomycin,
Shr1210
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use